Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (21-30 of 217) with videos related to

Pageof 22
Sort By:
Journal of Medical Virology|October 26, 2006
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavirNicola Gianotti, Laura Galli, Anna Danise, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2021
Changes in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) Index in Treated HIV-1 Infected People on Virological Suppression Who Switched to a Different Antiretroviral RegimenCamilla Muccini, Laura Galli, Andrea Poli, et al.
Journal of Medical Virology|December 26, 2003
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapyNicola Gianotti, Alessandro Soria, Laura Galli, et al.
AIDS (London, England)|October 8, 2013
Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirineAlessia Carbone, Alba Bigoloni, Laura Galli, et al.
AIDS (London, England)|December 20, 2007
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivityAndrea Caumo, Monica Guffanti, Gianluca Perseghin, et al.
Antiviral Therapy|February 2, 2012
Mortality of HIV-infected patients with or without cancer: comparison with the general population in ItalyLaura Galli, Vincenzo Spagnuolo, Stefania Salpietro, et al.
Pediatric Endocrinology Reviews : PER|January 27, 2006
Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic ricketsGiampiero Igli Baroncelli, Silvano Bertelloni, Federica Sodini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapyCaterina Uberti-Foppa, Anna De Bona, Giulia Morsica, et al.
AIDS (London, England)|July 17, 2007
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavirNicola Gianotti, Monica Guffanti, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected IndividualsCamilla Muccini, Laura Galli, Vincenzo Spagnuolo, et al.
Pageof 22

Showing results (21-30 of 217) with videos related to

Sort By:
Pageof 22
Journal of Medical Virology|October 26, 2006
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavirNicola Gianotti, Laura Galli, Anna Danise, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2021
Changes in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) Index in Treated HIV-1 Infected People on Virological Suppression Who Switched to a Different Antiretroviral RegimenCamilla Muccini, Laura Galli, Andrea Poli, et al.
Journal of Medical Virology|December 26, 2003
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapyNicola Gianotti, Alessandro Soria, Laura Galli, et al.
AIDS (London, England)|October 8, 2013
Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirineAlessia Carbone, Alba Bigoloni, Laura Galli, et al.
AIDS (London, England)|December 20, 2007
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivityAndrea Caumo, Monica Guffanti, Gianluca Perseghin, et al.
Antiviral Therapy|February 2, 2012
Mortality of HIV-infected patients with or without cancer: comparison with the general population in ItalyLaura Galli, Vincenzo Spagnuolo, Stefania Salpietro, et al.
Pediatric Endocrinology Reviews : PER|January 27, 2006
Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic ricketsGiampiero Igli Baroncelli, Silvano Bertelloni, Federica Sodini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapyCaterina Uberti-Foppa, Anna De Bona, Giulia Morsica, et al.
AIDS (London, England)|July 17, 2007
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavirNicola Gianotti, Monica Guffanti, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected IndividualsCamilla Muccini, Laura Galli, Vincenzo Spagnuolo, et al.
Pageof 22